CD8A and neoplasm: Second, the activity of tumor-infiltrating CD4+ and CD8+ T cells was significantly enhanced by the combined treatment of MβCD and cisplatin, to a similar extent enhanced by cisplatin treatment alone (Fig. 8F–I).